DRUG Bright Minds Biosciences Inc.

$21.63 -17.28%

Data as of Nov 3, 2026 close

Healthcare · Pharmaceutical Preparations

Bright Minds Biosciences Inc. (DRUG) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $98 million. Shares last traded at $21.63, 82.5% below their 52-week high. Over the past year the stock is down 60.3%.

Market Cap

$98M

Shares Out

4.5M

EPS (TTM)

—

P/E (TTM)*

—

P/S Ratio

—

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$123.74

52-Week Low

$19.00

Volume (venue)

26,871

Avg Vol (3m, venue)

7,805.111

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Bright Minds Biosciences Inc. reports in CAD: EPS, dividends and financials are shown in CAD as filed. P/E, P/S, P/B and yield convert them at 1 CAD = 0.7165 USD on 2026-10-30 (Federal Reserve H.10 via FRED, DEXCAUS).

Performance

-60.15%

-56.34%

-72.94%

-74.83%

YTD

-72.41%

-60.30%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

20.94

SMA (50)

$57.07

SMA (200)

$72.60

Price vs SMA50

-62.10%

Price vs SMA200

-70.20%

ATR (14)

$5.56

Full technical analysis (26 indicators, D/W/M) →

Pharmaceutical Preparations peers

DRUG vs 14 industry peers (Pharmaceutical Preparations), by market cap. Data as of Nov 3, 2026 close

1–14 of 14


LLY	Lilly (Eli)	$1.33T	48.07	15.33	31.9%	-0.17%
JNJ	Johnson & Johnson	$640.8B	39.81	6.45	16.2%	-1.62%
ONC	Beone Medicines Ltd.	$524.6B	800.05	85.59	10.7%	-1.72%
ABBV	AbbVie	$505.3B	48.86	7.66	15.7%	-1.00%
MRK	Merck	$357.0B	112.50	5.36	4.8%	-2.57%
ABT	Abbott Laboratories	$190.6B	30.37	4.22	13.9%	-0.77%
PFE	Pfizer	$170.9B	42.37	2.69	6.3%	-2.38%
VRTX	Vertex Pharmaceuticals	$134.7B	33.87	10.40	30.7%	-4.18%
BMY	Bristol Myers Squibb	$126.1B	13.65	2.52	18.5%	-2.09%
REGN	Regeneron Pharmaceuticals	$100.7B	20.91	5.96	28.5%	+1.30%
TEVA	Teva Pharmaceutical Industries Ltd	$48.9B	96.62	2.84	2.9%	+3.00%
ZTS	Zoetis	$34.3B	13.11	3.60	27.5%	-0.18%
RPRX	Royalty Pharma Plc	$29.5B	36.25	11.65	32.1%	-0.26%
ROIV	Roivant Sciences Ltd.	$26.0B	—	3458.17	—	+0.47%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in CAD) · Databento EQUS.MINI (prices) · FX: 1 CAD = 0.7165 USD on 2026-10-30 (Federal Reserve H.10 via FRED, DEXCAUS) · market cap & yield computed by tradmap. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.